New hope for dialysis patients: drug targets dangerous phosphate levels
Disease control
Not yet recruiting
This study tests a new medicine called AP306 in 168 adults on maintenance hemodialysis who have high blood phosphate levels. The goal is to see if AP306 can safely lower phosphate to a healthier range. Participants will receive either AP306 or a placebo, and researchers will moni…
Phase: PHASE2 • Sponsor: R1 Therapeutics • Aim: Disease control
Last updated May 16, 2026 11:05 UTC